Treatment of severe ulcerative colitis;Traitement de la rectocolite ulcéro-hémorragique dans sa forme grave

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 10 II, 2004, Pages 984-991

  Bouhnik, Yoram ^a   Alvès, Arnaud ^a   Beau, Philippe ^b   Carbonnel, Franck ^c   Lévy, Patrick ^d  

^a HÔPITAL LARIBOISIÈRE   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; HEPARIN; INFLIXIMAB; METRONIDAZOLE; PREDNISOLONE; TACROLIMUS; TETRACYCLINE; VANCOMYCIN;

BLOOD TRANSFUSION; CLINICAL FEATURE; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERBARIC OXYGEN; INTENSIVE CARE; LEUKAPHERESIS; MEDICAL DECISION MAKING; MEGACOLON; PERITONITIS; REVIEW; THROMBOSIS; TOTAL PARENTERAL NUTRITION; TREATMENT INDICATION; ULCERATIVE COLITIS;

EID: 7044236795     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)95176-7     Document Type: Review

References (68)

1. Robert JH, Sachar DB, Aufses AH, Jr., Greenstein AJ. Management of severe hemorrhage in ulcerative colitis. Am J Surg 1990;159:550-5.
2. Daperno M, Sostegni R, Rocca R, Rigazio C, Scaglione N, Castellino F, et al. Review article: medical treatment of severe ulcerative colitis. Aliment Pharmacol Ther 2002;16 Suppl 4:7-12.
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955:1041-8.
4. Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 1991;86:187-90.
5. Hyde GM, Thillainayagam AV, Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol 1998;10:411-3.
6. Carbonnel F, Gargouri D, Lemann M, Beaugerie L, Cattan S, Cosnes J, et al. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000;14:273-9.
7. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210-2.
8. D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans L, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.
9. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;1:1067-70.
10. Truelove SC, Willoughby CP, Lee EG, Kettlewell MG. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;2:1086-8.
11. Dickinson RJ, Ashton MG, Axon AT, Smith RC, Yeung CK, Hill GL. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980;79:1199-204.
12. McIntyre PB, Powell-Tuck J, Wood SR, Lennard-Jones JE, Lerebours E, Hecketsweiler P, et al. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986;27:481-5.
13. Sitzmann JV, Converse RL, Jr., Bayless TM. Favorable response to parenteral nutrition and medical therapy in Crohn's colitis. A report of 38 patients comparing severe Crohn's and ulcerative colitis. Gastroenterology 1990;99:1647-52.
14. Carbonnel F, Lavergne A, Lemann M, Bitoun A, Valleur P, Hautefeuille P, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994;39:1550-7.
15. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10.
16. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
17. Almer S, Bodemar G, Franzen L, Lindstrom E, Nystrom P, Strom M, Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis. Lancet 1996;347:1731-5.
18. Rambaud JC, Carbonnel F, Bitoun A, Lavergne-Slove A. Colonoscopy to assess ulcerative colitis. Lancet 1996;348:625.
19. Nahon S, Bouhnik Y, Lavergne-Slove A, Bitoun A, Panis Y, Valleur P, et al. Colonoscopy accurately predicts the anatomical severity of colonic Crohn's disease attacks: correlation with findings from colectomy specimens. Am J Gastroenterol 2002;97:3102-7.
20. Jalan KN, Sircus W, Card WI, Falconer CW, Brace CB, Crean GP, et al. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology 1969;57:68-82.
21. Wada Y, Matsui T, Matake H, Sakurai T, Yamamoto J, Kikuchi Y, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 2003;46:S59-65.
22. Vega R, Bertran X, Menacho M, Domenech E, De Vega VM, Hombrados M, et al. Cytomegaloviras infection in patients with inflammatory bowel disease. American Journal of Gastroenterology 1999;94:1053-6.
23. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985;89:1005-13.
24. Elliott PR, Powell-Tuck J, Gillespie PE, Laidlow JM, Lennard-Jones JE, English J, et al. Prednisolone absorption in acute colitis. Gut 1980;21:49-51.
25. Baron JH, Connell AM, Kanaghinis TG, Lennard-Jones JE, Jones AF. Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone. Br Med J 1962;5302:441-3.
26. Dickinson RJ, O'Connor HJ, Pinder I, Hamilton I, Johnston D, Axon AT. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985;26:1380-4.
27. Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Kourtessas D, Christidou A, et al. A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand J Gastroenterol 2001;36:971-4.
28. Marion JF, Present DH. The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 1997;9:831-5.
29. Dunckley P, Jewell D. Management of acute severe colitis. Best Pract Res Clin Gastroenterol 2003;17:89-103.
30. Carbonnel F, Borachowicz A, Duclos B, Soule JC, Lerebours E, Lemann M, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 1996;41:2471-6.
31. Sandborn WJ. Cyclosporine in ulcerative colitis: state of the art. Acta Gastroenterol Belg 2001;64:201-4.
32. Fernandez-Banares F, Bertran X, Esteve-Comas M, Cabre E, Menacho M, Humbert P, et al. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. Am J Gastroenterol 1996;91:2498-9.
33. Actis GC, Bresso F, Astegiano M, Demarchi B, Sapone N, Boscaglia C, et al. Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther 2001;15:1307-11.
34. Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31.
35. Actis GC, Aimo G, Priolo G, Moscato D, Rizzetto M, Pagni R. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis 1998;4:276-9.
36. Navazo L, Salata H, Morales S, Dorta MC, Perez F, de las Casas D, et al. Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis. Scand J Gastroenterol 2001;36:610-4.
37. Actis GC, Volpes R, Rizzetto M. Oral microemulsion cyclosporin to reduce steroids rapidly in chronic active ulcerative colitis. Eur J Gastroenterol Hepatol 1999;11:905-8.
38. Svanoni F, Bonassi U, Bagnolo F, Caporuscio S. Effectiveness of ciclosporine A (CsA) in the treatment of active refractory ulcerative colitis (UC). gastroenterology 1998;114:A1096.
39. Fellermann K, Tanko Z, Herrlinger KR, Witthoeft T, Homann N, Bruening A, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflammatory Bowel Diseases 2002;8:317-24.
40. Hogenauer C, Wenzl HH, Hinterleitner TA, Petritsch W. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther 2003;18:415-23.
41. Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003;17:1273-81.
42. Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001;7:83-8.
43. Gornet JM, Couve S, Hassani Z, Delchier JC, Marteau P, Cosnes J, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study. Aliment Pharmacol Ther 2003;18:175-81.
44. Probert CS, Hearing SD, Schreiber S, Kuhbacher T, Ghosh S, Arnott ID, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut 2003;52:998-1002.
45. Korzenik JR, Miner P, Stanton D. Multicenter double blind placebo controlled trial of deligoparin (ultralow molecular weight heparin) for active ulcerative colitis. Gastroenterology 2003;124:A67.
46. Kohgo Y, Hibi H, Chiba T, Shimoyama T, Muto T, Yamamura K, et al. Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial. Ther Apher 2002;6:255-60.
47. Alves A, Panis Y, Bouhnik Y, Maylin V, Lavergne-Slove A, Valleur P. Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy. J Am Coll Surg 2003;197:379-85.
48. Penna C, Daude F, Parc R, Tiret E, Frileux P, Hannoun L, et al. Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum 1993;36:343-8.
49. Harms BA, Myers GA, Rosenfeld DJ, Starling JR. Management of fulminant ulcerative colitis by primary restorative proctocolectomy. Dis Colon Rectum 1994;37:971-8.
50. Bell RL, Seymour NE. Laparoscopic treatment of fulminant ulcerative colitis. Surg Endosc 2002;16:1778-82.
51. Marcello PW, Milsom JW, Wong SK, Brady K, Goormastic M, Fazio VW. Laparoscopic total colectomy for acute colitis: a case-control study. Dis Colon Rectum 2001;44:1441-5.
52. Dunker MS, Bemelman WA, Slors JF, van Hogezand RA, Ringers J, Gouma DJ. Laparoscopic-assisted vs open colectomy for severe acute colitis in patients with inflammatory bowel disease (IBD): a retrospective study in 42 patients. Surg Endosc 2000;14:911-4.
53. Carter FM, McLeod RS, Cohen Z. Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant. Dis Colon Rectum 1991;34:1005-9.
54. Ziv Y, Fazio VW, Church JM, Milsom JW, Schroeder TK. Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis. Dis Colon Rectum 1995;38:345-9.
55. Binder SC, Miller HH, Deterling RA, Jr. Emergency and urgent operations for ulcerative colitis. The procedure of choice. Arch Surg 1975;110:284-9.
56. Hawley PR. Emergency surgery for ulcerative colitis. World J Surg 1988;12:169-73.
57. Utlisation des solutions d'albumine humaine en anesthésie chirurgicale et en rénimation chirurgicale chez l'adulte. Conférence de consensus. Saint Mandé. 15 Décembre 1995. Ann Fr Anesth Reanim 1996;15:407-568.
58. Practice guidelines for blood component therapy: a report by the american society of anesthesiologists task force on blood component therapy. Anesthesiology 1996;84:732-47.
59. Talbot RW, Heppell J, Dozois RR, Beart RW, Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-5.
60. Mallant-Hent RC, Van Bodegraven AA, Meuwissen SGM, Manoliu RA. Alternative approach to massive gastrointestinal bleeding in ulcerative colitis: Highly selective transcatheter embolization. European Journal of Gastroenterology and Hepatology 2003;15:189-93.
61. Yoshida Y, Kawaguchi A, Mataki N, Matsuzaki K, Hokari R, Iwai A, et al. Endoscopic treatment of massive lower GI hemorrhage in two patients with ulcerative colitis. Gastrointest Endosc 2001;54:779-81.
62. Greenstein AJ, Earth JA, Sachar DB, Aufses AH, Jr. Free colonic perforation without dilatation in ulcerative colitis. Am J Surg 1986;152:272-5.
63. Heppell J, Farkouh E, Dube S, Peloquin A, Morgan S, Bernard D. Toxic megacolon. An analysis of 70 cases. Dis Colon Rectum 1986;29:789-92.
64. Grant CS, Dozois RR. Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg 1984;147:106-10.
65. Present DH, Wolfson D, Gelernt IM, Rubin PH, Bauer J, Chapman ML. Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol 1988;10:485-90.
66. Latella G, Vernia P, Viscido A, Frieri G, Cadau G, Cocco A, et al. GI distension in severe ulcerative colitis. Am J Gastroenterol 2002;97:1169-75.
67. Riedler L, Wohlgenannt D, Stoss F, Thaler W, Schmid KW. Endoscopic decompression in "toxic megacolon". Surg Endosc 1989;3:51-3.
68. Kuroki K, Masuda A, Uehara H, Kuroki A. A new treatment for toxic megacolon. Lancet 1998;352:782.